Virginia Park Winn
Athletic Trainer at Adams St, Denver, CO
License number
Colorado 1206
Issued Date
Jul 30, 2013
Renew Date
Jul 1, 2016
Expiration Date
Oct 31, 2017
Type
Athletic Trainer
Address
Address
1418 Adams St APT 203, Denver, CO 80206
Personal information
See more information about Virginia Park Winn at radaris.comName
Address
Phone
726 S 9Th Ave, Brighton, CO 80601
1055 S High St, Denver, CO 80209
2807 Geneva St, Denver, CO 80238
Hayden, CO
Professional information
Dr. Virginia D Winn - MD (Doctor of Medicine)
Hospitals:
12605 E 16Th Ave, Aurora 80045
1772 Platte St, Denver 80202
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16Th Avenue Dr, Aurora 80045
12605 E 16Th Ave, Aurora 80045
1772 Platte St, Denver 80202
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16Th Avenue Dr, Aurora 80045
1772 Platte St, Denver 80202
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16Th Avenue Dr, Aurora 80045
12605 E 16Th Ave, Aurora 80045
1772 Platte St, Denver 80202
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16Th Avenue Dr, Aurora 80045
Education:
Medical Schools
University Of Rochester School Of Medicine and Dentistry
Graduated: 1990
University Of Rochester School Of Medicine and Dentistry
Graduated: 1990
Biomarkers For Preeclampsia
US Patent:
2008023, Sep 25, 2008
Filed:
Feb 20, 2008
Appl. No.:
12/034458
Inventors:
Susan J. Fisher - San Francisco CA, US
Virginia D. Winn - Denver CO, US
Ronit Haimov-Kochman - Mevasseret Zion, IL
Virginia D. Winn - Denver CO, US
Ronit Haimov-Kochman - Mevasseret Zion, IL
Assignee:
REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
C12Q 1/68, G01N 33/566, G01N 33/50, G01N 33/567
US Classification:
435 6, 436501, 436 94, 435 721
Abstract:
The present invention provides methods for predicting the development of and diagnosing preeclampsia, providing a prognosis, and predicting recurrence of the disease using molecular markers that are overexpressed or underexpressed in preeclampia. Also provided are methods to identify compounds that are useful for the treatment or prevention of preeclampsia.